Mol Cancer. 2022;21:114. Article CAS PubMed PubMed Central Google Scholar Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. ...
Global Cancer Statistics 2020: Globocan Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. Ca-a Cancer Journal for Clinicians. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660. Article CAS PubMed Google Scholar Webb PM, Jordan SJ. Epidemiology of ...
Ovarian cancer is an aggressive disease that is frequently detected at advanced stages and is initially very responsive to platinum-based chemotherapy. However, the majority of patients relapse following initial surgery and chemotherapy, highlighting the urgent need to develop new therapeutic strategies. ...
Cancer stem cells (CSCs) are thought to be the core reason behind tumor clonal evolution [106], and thus widely believed to be the driving force behind tumor progression [107]. Cells with CSC characteristics have been isolated from OC cell lines [108,109]. EMT is also thought to relate t...
Ovarian cancer (OC) remains one of the most challenging and deadly malignancies facing women today. While PARP inhibitors (PARPis) have transformed the treatment landscape for women with advanced OC, many patients will relapse and the PARPi-resistant set
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. Article PubMed Google Scholar Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30. ...
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71:209–49. https://doi.org/10.3322/caac.21660.Search in Google Scholar PubMed 2. Lheureux, S, Braunstein, M, Oza, AM. Epithelial ovarian cancer...
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 Int. J. Cancer, 136 (5) (2015), pp. E359-E386 View in ScopusGoogle Scholar [2] M. Markman, et al. Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin...
Ovarian cancer stands as the deadliest gynecologic malignancy, responsible for nearly 65% of all gynecologic cancer-related deaths. The challenges in early detection and diagnosis, coupled with the widespread intraperitoneal spread of cancer cells and re
Ovarian cancer (OC) is one the most life-threatening cancers affecting women’s health worldwide. Immunotherapy has become a promising treatment for a variety of cancers, but the therapeutic effects in OC remain limited. In this study, we constructed a m